Uloric (febuxostat): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

UPDATE: Perform Only Contained Morcellation When Laparoscopic Power Morcellation Is Appropriate: FDA Safety Communication

30-12-2020

This update to the February 2020 safety communication provides information on the final guidance, Product Labeling for Laparoscopic Power...